Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003107557 | SCV003794542 | pathogenic | Pyruvate dehydrogenase E2 deficiency | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon(s) 1-4 of the DLAT gene, which includes the initiator codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DLAT are known to be pathogenic (PMID: 20022530, 23021068). This variant has not been reported in the literature in individuals affected with DLAT-related conditions. For these reasons, this variant has been classified as Pathogenic. |